tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Quest Diagnostics price target lowered to $190 from $200 at Piper Sandler

Piper Sandler analyst David Westenberg lowered the firm’s price target on Quest Diagnostics (DGX) to $190 from $200 following quarterly results. The firm keeps a Neutral rating on the shares.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1